{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:08:08Z","timestamp":1793333288323,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774213"],"award-info":[{"award-number":["81774213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174299"],"award-info":[{"award-number":["82174299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973802"],"award-info":[{"award-number":["81973802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074424"],"award-info":[{"award-number":["82074424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673949"],"award-info":[{"award-number":["81673949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Sci Food"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Stigmasterol (ST) has been shown to improve both lipid and bile acid (BA) metabolism. However, the mechanism(s) by which ST prevents dyslipidemia via BA metabolism, and the potential involvement of other regulatory mechanisms, remains unclear. Here, we found that ST treatment effectively alleviates lipid metabolism disorder induced by a high-fat diet (HFD). Moreover, we also show that fecal microbiota transplantation from ST-treated rats displays similar protective effects in rats fed on an HFD. Our data confirm that the gut microbiota plays a key role in attenuating HFD-induced fat deposition and metabolic disorders. In particular, ST reverses HFD-induced gut microbiota dysbiosis in rats by reducing the relative abundance of\n                    <jats:italic>Erysipelotrichaceae<\/jats:italic>\n                    and\n                    <jats:italic>Allobaculum<\/jats:italic>\n                    bacteria in the gut. In addition, ST treatment also modifies the serum and fecal BA metabolome profiles in rats, especially in CYP7A1 mediated BA metabolic pathways. Furthermore, chenodeoxycholic acid combined with ST improves the therapeutic effects in HFD-induced dyslipidemia and hepatic steatosis. In addition, this treatment strategy also alters BA metabolism profiles via the CYP7A1 pathway and gut microbiota. Taken together, ST exerts beneficial effects against HFD-induced hyperlipidemia and obesity with the underlying mechanism being partially related to both the reprogramming of the intestinal microbiota and metabolism of BAs in enterohepatic circulation. This study provides a theoretical basis for further study of the anti-obesity effects of ST and consideration of the gut microbiota as a potential target for the treatment of HFD-induced dyslipidemia.\n                  <\/jats:p>","DOI":"10.1038\/s41538-022-00156-0","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T02:04:36Z","timestamp":1661565876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism"],"prefix":"10.1038","volume":"6","author":[{"given":"Yaxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saibo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0431-9532","authenticated-orcid":false,"given":"Fenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"156_CR1","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc11-0816","volume":"34","author":"S Malik","year":"2011","unstructured":"Malik, S. et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care 34, 2285\u20132290 (2011).","journal-title":"Diabetes Care"},{"key":"156_CR2","first-page":"78","volume":"95","author":"AR Last","year":"2017","unstructured":"Last, A. R., Ference, J. D. & Menzel, E. R. Hyperlipidemia: Drugs for cardiovascular risk reduction in adults. Am. Fam. Phys. 95, 78\u201387 (2017).","journal-title":"Am. Fam. Phys."},{"key":"156_CR3","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2337\/dc15-2450","volume":"39","author":"C Hero","year":"2016","unstructured":"Hero, C. et al. Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes. Diabetes Care 39, 996\u20131003 (2016).","journal-title":"Diabetes Care"},{"key":"156_CR4","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1021\/acs.biochem.6b00342","volume":"55","author":"NM Cerqueira","year":"2016","unstructured":"Cerqueira, N. M. et al. Cholesterol biosynthesis: A mechanistic overview. Biochemistry 55, 5483\u20135506 (2016).","journal-title":"Biochemistry"},{"key":"156_CR5","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1172\/JCI21025","volume":"113","author":"M Watanabe","year":"2004","unstructured":"Watanabe, M. et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113, 1408\u20131418 (2004).","journal-title":"J. Clin. Invest."},{"key":"156_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nay. Rev. Drug Discov. 7, 678\u2013693 (2008).","journal-title":"Nay. Rev. Drug Discov."},{"key":"156_CR7","doi-asserted-by":"publisher","first-page":"1941710","DOI":"10.1080\/19490976.2021.1941710","volume":"13","author":"M Avril","year":"2021","unstructured":"Avril, M. & DePaolo, R. W. \u201cDriver-passenger\u201d bacteria and their metabolites in the pathogenesis of colorectal cancer. Gut Microbes 13, 1941710 (2021).","journal-title":"Gut Microbes"},{"key":"156_CR8","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1111\/cas.15142","volume":"112","author":"N Ohtani","year":"2021","unstructured":"Ohtani, N. & Hara, E. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Cancer Sci. 112, 4433\u20134443 (2021).","journal-title":"Cancer Sci."},{"key":"156_CR9","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/jcb.27635","volume":"120","author":"J Chen","year":"2019","unstructured":"Chen, J., Thomsen, M. & Vitetta, L. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. J. Cell Biochem. 120, 2713\u20132720 (2019).","journal-title":"J. Cell Biochem."},{"key":"156_CR10","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","volume":"111","author":"SA Joyce","year":"2014","unstructured":"Joyce, S. A. et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc. Natl Acad. Sci. USA 111, 7421\u20137426 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"156_CR11","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1021\/acs.jafc.7b06146","volume":"66","author":"S Feng","year":"2018","unstructured":"Feng, S. et al. Effects of stigmasterol and beta-sitosterol on nonalcoholic fatty liver disease in a mouse model: A lipidomic analysis. J. Agric Food Chem. 66, 3417\u20133425 (2018).","journal-title":"J. Agric Food Chem."},{"key":"156_CR12","doi-asserted-by":"publisher","first-page":"688036","DOI":"10.3389\/fimmu.2021.688036","volume":"12","author":"Y Takahashi","year":"2021","unstructured":"Takahashi, Y. et al. Interleukin-22 deficiency contributes to dextran sulfate sodium-induced inflammation in Japanese Medaka, Oryzias latipes. Front. Immunol. 12, 688036 (2021).","journal-title":"Front. Immunol."},{"key":"156_CR13","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.2174\/0929867326666190822154701","volume":"26","author":"L Cedo","year":"2019","unstructured":"Cedo, L., Farras, M., Lee-Rueckert, M. & Escola-Gil, J. C. Molecular insights into the mechanisms underlying the cholesterol-lowering effects of phytosterols. Curr. Med. Chem. 26, 6704\u20136723 (2019).","journal-title":"Curr. Med. Chem."},{"key":"156_CR14","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00394-019-02119-w","volume":"59","author":"YP Chau","year":"2020","unstructured":"Chau, Y. P. et al. The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: A double-blind randomized controlled trial. Eur. J. Nutr. 59, 2739\u20132746 (2020).","journal-title":"Eur. J. Nutr."},{"key":"156_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2013.08.012","volume":"230","author":"RT Ras","year":"2013","unstructured":"Ras, R. T. et al. Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations\u2014a meta-analysis of randomized controlled studies. Atherosclerosis 230, 336\u2013346 (2013).","journal-title":"Atherosclerosis"},{"key":"156_CR16","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.lfs.2007.02.032","volume":"80","author":"L Calpe-Berdiel","year":"2007","unstructured":"Calpe-Berdiel, L. et al. Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation. Life Sci. 80, 1951\u20131956 (2007).","journal-title":"Life Sci."},{"key":"156_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bbalip.2018.08.004","volume":"1863","author":"S Feng","year":"2018","unstructured":"Feng, S. et al. Intake of stigmasterol and beta-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863, 1274\u20131284 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"156_CR18","doi-asserted-by":"publisher","first-page":"113099","DOI":"10.1016\/j.jep.2020.113099","volume":"260","author":"D Rout","year":"2020","unstructured":"Rout, D., Chandra, D. U., Kanhar, S., Swain, S. K. & Sahoo, A. K. The modulatory role of prime identified compounds in the bioactive fraction of Homalium zeylanicum in high-fat diet fed-streptozotocin-induced type 2 diabetic rats. J. Ethnopharmacol. 260, 113099 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"156_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.fct.2012.12.029","volume":"53","author":"FJ Dai","year":"2013","unstructured":"Dai, F. J., Hsu, W. H., Huang, J. J. & Wu, S. C. Effect of pigeon pea (Cajanus cajan L.) on high-fat diet-induced hypercholesterolemia in hamsters. Food Chem. Toxicol. 53, 384\u2013391 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"156_CR20","doi-asserted-by":"publisher","first-page":"741934","DOI":"10.3389\/fimmu.2021.741934","volume":"12","author":"S Wen","year":"2021","unstructured":"Wen, S. et al. Stigmasterol restores the balance of Treg\/Th17 cells by activating the butyrate-PPARgamma axis in colitis. Front. Immunol. 12, 741934 (2021).","journal-title":"Front. Immunol."},{"key":"156_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-food-041715-033159","volume":"7","author":"SA Joyce","year":"2016","unstructured":"Joyce, S. A. & Gahan, C. G. Bile acid modifications at the microbe\u2013host interface: Potential for nutraceutical and pharmaceutical interventions in host health. Annu. Rev. Food Sci. Technol. 7, 313\u2013333 (2016).","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"156_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12944-020-1201-6","volume":"19","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: A cross sectional study. Lipids Health Dis. 19, 18 (2020).","journal-title":"Lipids Health Dis."},{"key":"156_CR23","doi-asserted-by":"crossref","unstructured":"Papotti, B., Escola-Gil, J. C., Julve, J., Poti, F. & Zanotti, I. Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies. Nutrients 13, 2643 (2021).","DOI":"10.3390\/nu13082643"},{"key":"156_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","volume":"4","author":"J Chiang","year":"2020","unstructured":"Chiang, J. & Ferrell, J. M. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res. 4, 47\u201363 (2020).","journal-title":"Liver Res."},{"key":"156_CR25","doi-asserted-by":"crossref","unstructured":"Chambers, K. F., Day, P. E., Aboufarrag, H. T. & Kroon, P. A. Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: A review. Nutrients 11, 2588 (2019).","DOI":"10.3390\/nu11112588"},{"key":"156_CR26","doi-asserted-by":"crossref","unstructured":"Xue, R. et al. Bile acid receptors and the gut-liver axis in nonalcoholic fatty liver disease. Cells 10, 2806 (2021).","DOI":"10.3390\/cells10112806"},{"key":"156_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2017.05.015","volume":"172","author":"T Yang","year":"2017","unstructured":"Yang, T. et al. Quantitative profiling of 19 bile acids in rat plasma, liver, bile, and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids. J. Steroid Biochem. Mol. Biol. 172, 69\u201378 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"156_CR28","doi-asserted-by":"publisher","first-page":"G263","DOI":"10.1152\/ajpgi.00111.2012","volume":"303","author":"RD Jones","year":"2012","unstructured":"Jones, R. D., Repa, J. J., Russell, D. W., Dietschy, J. M. & Turley, S. D. Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-\/-) mice fed low levels of cholic acid. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G263\u2013G274 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"156_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12876-018-0842-7","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: Evidence from a human metabolomic study and in vitro experiments. BMC Gastroenterol. 18, 112 (2018).","journal-title":"BMC Gastroenterol."},{"key":"156_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"156_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li, F. et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4, 2384 (2013).","journal-title":"Nat. Commun."},{"key":"156_CR32","first-page":"5305","volume":"14","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. Chenodeoxycholic acid attenuates high-fat diet-induced obesity and hyperglycemia via the G protein-coupled bile acid receptor 1 and proliferator-activated receptor gamma pathway. Exp. Ther. Med. 14, 5305\u20135312 (2017).","journal-title":"Exp. Ther. Med."},{"key":"156_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","volume":"22","author":"EP Broeders","year":"2015","unstructured":"Broeders, E. P. et al. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab. 22, 418\u2013426 (2015).","journal-title":"Cell Metab."},{"key":"156_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mce.2015.07.012","volume":"414","author":"MS Shihabudeen","year":"2015","unstructured":"Shihabudeen, M. S., Roy, D., James, J. & Thirumurugan, K. Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance. Mol. Cell Endocrinol. 414, 19\u201328 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"156_CR35","doi-asserted-by":"publisher","first-page":"G840","DOI":"10.1152\/ajpgi.00029.2015","volume":"308","author":"MK Hamilton","year":"2015","unstructured":"Hamilton, M. K., Boudry, G., Lemay, D. G. & Raybould, H. E. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G840\u2013G851 (2015).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"156_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijbiomac.2017.02.074","volume":"99","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats. Int. J. Biol. Macromol. 99, 282\u2013292 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"156_CR37","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"PD Cani","year":"2008","unstructured":"Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470\u20131481 (2008).","journal-title":"Diabetes"},{"key":"156_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2008","unstructured":"Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453\u2013461 (2008).","journal-title":"Front. Biosci."},{"key":"156_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1017\/S0007114514001172","volume":"112","author":"B Benoit","year":"2014","unstructured":"Benoit, B. et al. Pasture v. standard dairy cream in high-fat diet-fed mice: Improved metabolic outcomes and stronger intestinal barrier. Br. J. Nutr. 112, 520\u2013535 (2014).","journal-title":"Br. J. Nutr."},{"key":"156_CR40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/mnfr.201500703","volume":"60","author":"M Lecomte","year":"2016","unstructured":"Lecomte, M. et al. Dietary emulsifiers from milk and soybean differently impact adiposity and inflammation in association with modulation of colonic goblet cells in high-fat fed mice. Mol. Nutr. Food Res. 60, 609\u2013620 (2016).","journal-title":"Mol. Nutr. Food Res."},{"key":"156_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"156_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12866-019-1494-7","volume":"19","author":"BJ Smith","year":"2019","unstructured":"Smith, B. J. et al. Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice. BMC Microbiol. 19, 130 (2019).","journal-title":"BMC Microbiol."},{"key":"156_CR43","doi-asserted-by":"publisher","first-page":"110530","DOI":"10.1016\/j.foodres.2021.110530","volume":"147","author":"TT Li","year":"2021","unstructured":"Li, T. T. et al. Spirulina platensis polysaccharides attenuate lipid and carbohydrate metabolism disorder in high-sucrose and high-fat diet-fed rats in association with intestinal microbiota. Food Res. Int. 147, 110530 (2021).","journal-title":"Food Res. Int."},{"key":"156_CR44","doi-asserted-by":"publisher","first-page":"149602","DOI":"10.1016\/j.scitotenv.2021.149602","volume":"800","author":"C Jin","year":"2021","unstructured":"Jin, C. et al. Propamocarb exposure has the potential to accelerate the formation of atherosclerosis in both WT and ApoE(-\/-) mice accompanied by gut microbiota dysbiosis. Sci. Total Environ. 800, 149602 (2021).","journal-title":"Sci. Total Environ."},{"key":"156_CR45","doi-asserted-by":"publisher","first-page":"e9591","DOI":"10.7717\/peerj.9591","volume":"8","author":"X Li","year":"2020","unstructured":"Li, X. et al. Regional distribution of Christensenellaceae and its associations with metabolic syndrome based on a population-level analysis. PEERJ 8, e9591 (2020).","journal-title":"PEERJ"},{"key":"156_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-019-0699-4","volume":"17","author":"JL Waters","year":"2019","unstructured":"Waters, J. L. & Ley, R. E. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol. 17, 83 (2019).","journal-title":"BMC Biol."},{"key":"156_CR47","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1007\/s00253-019-09764-5","volume":"103","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. Antibiotics-induced perturbations in gut microbial diversity influence metabolic phenotypes in a murine model of high-fat diet-induced obesity. Appl. Microbiol. Biotechnol. 103, 5269\u20135283 (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"156_CR48","doi-asserted-by":"crossref","unstructured":"Guo, S. et al. Anti-obesity and gut microbiota modulation effect of secoiridoid-enriched extract from Fraxinus mandshurica seeds on high-fat diet-fed mice. Molecules 25, 4001 (2020).","DOI":"10.3390\/molecules25174001"},{"key":"156_CR49","doi-asserted-by":"crossref","unstructured":"Mazier, W. et al. A new strain of christensenella minuta as a potential biotherapy for obesity and associated metabolic diseases. Cells 10, 823 (2021).","DOI":"10.3390\/cells10040823"},{"key":"156_CR50","doi-asserted-by":"publisher","first-page":"722206","DOI":"10.3389\/fimmu.2021.722206","volume":"12","author":"Y Que","year":"2021","unstructured":"Que, Y. et al. Gut bacterial characteristics of patients with type 2 diabetes mellitus and the application potential. Front. Immunol. 12, 722206 (2021).","journal-title":"Front. Immunol."},{"key":"156_CR51","doi-asserted-by":"publisher","first-page":"718661","DOI":"10.3389\/fnut.2021.718661","volume":"8","author":"TS Dong","year":"2021","unstructured":"Dong, T. S. et al. The intestinal microbiome predicts weight loss on a calorie-restricted diet and is associated with improved hepatic steatosis. Front. Nutr. 8, 718661 (2021).","journal-title":"Front. Nutr."},{"key":"156_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.it.2012.02.008","volume":"33","author":"R Pappu","year":"2012","unstructured":"Pappu, R., Rutz, S. & Ouyang, W. Regulation of epithelial immunity by IL-17 family cytokines. Trends Immunol. 33, 343\u2013349 (2012).","journal-title":"Trends Immunol."},{"key":"156_CR53","doi-asserted-by":"publisher","first-page":"115276","DOI":"10.1016\/j.envpol.2020.115276","volume":"266","author":"J Zhan","year":"2020","unstructured":"Zhan, J. et al. Gut microbiome alterations induced by tributyltin exposure are associated with increased body weight, impaired glucose and insulin homeostasis, and endocrine disruption in mice. Environ. Pollut. 266, 115276 (2020).","journal-title":"Environ. Pollut."},{"key":"156_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0602-5","volume":"6","author":"J Zhan","year":"2018","unstructured":"Zhan, J. et al. Antibiotics may increase triazine herbicide exposure risk via disturbing gut microbiota. Microbiome 6, 224 (2018).","journal-title":"Microbiome"},{"key":"156_CR55","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1142\/S0192415X21500683","volume":"49","author":"YX Zhang","year":"2021","unstructured":"Zhang, Y. X. et al. The role of ophiopogonin D in atherosclerosis: Impact on lipid metabolism and gut microbiota. Am. J. Chin. Med. 49, 1449\u20131471 (2021).","journal-title":"Am. J. Chin. Med."},{"key":"156_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aba3683","volume":"373","author":"W Yoo","year":"2021","unstructured":"Yoo, W. et al. High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Science 373, 813\u2013818 (2021).","journal-title":"Science"}],"container-title":["npj Science of Food"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41538-022-00156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-022-00156-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41538-022-00156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T03:03:06Z","timestamp":1661569386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41538-022-00156-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["156"],"URL":"https:\/\/doi.org\/10.1038\/s41538-022-00156-0","relation":{},"ISSN":["2396-8370"],"issn-type":[{"value":"2396-8370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}